
|Videos|April 11, 2020
Weekly Webinar Series Part 2: Managing Lung Cancer Patients Through the COVID-19 Pandemic
Advertisement
Led by Nathan Pennell, MD, PhD; Stephen Liu, MD; Charu Aggarwal, MD, MPH; and H. Jack West, MD, these top leaders in the lung cancer space shared insights on the novel corona-virus disease 2019 (COVID-19) and how the pandemic is poised to have a significant impact on lung cancer treatment and the healthcare system.
Topics Include:
- Knowing the best practices before patients come to clinic
- How molecular testing is being impacted by COVID-19
- How is clinical trial enrollment being affected in the wake of the pandemic
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
4
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
5



































